Drugs / ATTO-1310
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06787586 | Jan 2025 → May 2026 overdue | atopic eczema | Attovia Therapeutics Inc | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ATTO-1310 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06787586 ↗ |
| Route | Intravenous | “receiving a single dose IV” NCT06787586 ↗ |